In short, Renflexis is a biosimilar infusion medication that blocks TNF-alpha to reduce inflammation in moderate to severe Crohn’s disease. The treatment involves intravenous infusions administered initially at specific intervals, then every eight weeks for maintenance. Regular monitoring during Renflexis therapy ensures safety and effectiveness while managing potential side effects. Understanding Crohn’s Disease Crohn’s disease
Read Moreabdominal pain
Is Infliximab an Effective Treatment for Crohn’s Disease?
In short, Infliximab is a TNF-alpha inhibitor used to reduce inflammation and control Crohn’s disease. Clinical studies show that infliximab and biosimilars like Renflexis are effective in inducing and maintaining remission. Ongoing monitoring is important to ensure safety and long-term success. Understanding Crohn’s Disease and the Role of Infliximab Crohn’s disease is a chronic inflammatory
Read MoreCrohn’s Disease Treatments: How Diet Plays a Role
Living with Crohn’s disease can be challenging, but understanding the impact of diet on your symptoms can be a game-changer. While foods are not the direct cause of Crohn’s disease, they can serve as triggers for your symptoms. Let us explore how you can use diet as part of your Crohn’s disease treatments. Introduction to
Read More
